People: Editas Medicine Inc (EDIT.OQ)
16 Aug 2019
Dr. Vickesh Myer is Chief Technology Officer of the Company. Prior to joining our company, Dr. Myer served as Executive Director, Cambridge Site Head, Developmental and Molecular Pathways Department at Novartis Institutes for Biomedical Research, a global pharmaceutical research organization of Novartis International AG, from April 2004 until April 2015. Dr. Myer received his B.S. in biology from Cornell University and his Ph.D. in molecular biophysics and biochemistry from Yale University.
|Total Annual Compensation, USD||486,926|
|Restricted Stock Award, USD||--|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||1,968,810|
|Fiscal Year Total, USD||2,455,740|